DBVT
Price
$13.05
Change
-$0.72 (-5.23%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
504.75M
Intraday BUY SELL Signals
GLSI
Price
$8.18
Change
-$0.14 (-1.68%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
115.13M
104 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

DBVT vs GLSI

Header iconDBVT vs GLSI Comparison
Open Charts DBVT vs GLSIBanner chart's image
DBV Technologies S.A
Price$13.05
Change-$0.72 (-5.23%)
Volume$1.3K
Capitalization504.75M
Greenwich LifeSciences
Price$8.18
Change-$0.14 (-1.68%)
Volume$520
Capitalization115.13M
DBVT vs GLSI Comparison Chart in %
DBVT
Daily Signal:
Gain/Loss:
GLSI
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
DBVT vs. GLSI commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DBVT is a Hold and GLSI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (DBVT: $13.77 vs. GLSI: $8.32)
Brand notoriety: DBVT and GLSI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DBVT: 136% vs. GLSI: 122%
Market capitalization -- DBVT: $510.23M vs. GLSI: $113.33M
DBVT [@Biotechnology] is valued at $510.23M. GLSI’s [@Biotechnology] market capitalization is $113.33M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.1B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DBVT’s FA Score shows that 0 FA rating(s) are green whileGLSI’s FA Score has 0 green FA rating(s).

  • DBVT’s FA Score: 0 green, 5 red.
  • GLSI’s FA Score: 0 green, 5 red.
According to our system of comparison, DBVT is a better buy in the long-term than GLSI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DBVT’s TA Score shows that 4 TA indicator(s) are bullish while GLSI’s TA Score has 4 bullish TA indicator(s).

  • DBVT’s TA Score: 4 bullish, 4 bearish.
  • GLSI’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, DBVT is a better buy in the short-term than GLSI.

Price Growth

DBVT (@Biotechnology) experienced а -2.34% price change this week, while GLSI (@Biotechnology) price change was -0.54% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.51%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +61.90%.

Reported Earning Dates

GLSI is expected to report earnings on Feb 25, 2026.

Industries' Descriptions

@Biotechnology (+1.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DBVT($505M) has a higher market cap than GLSI($115M). DBVT YTD gains are higher at: 345.631 vs. GLSI (-25.868). GLSI has higher annual earnings (EBITDA): -18.14M vs. DBVT (-115.51M). DBVT has more cash in the bank: 103M vs. GLSI (3.13M). DBVT (0) and GLSI (0) have equivalent revenues.
DBVTGLSIDBVT / GLSI
Capitalization505M115M439%
EBITDA-115.51M-18.14M637%
Gain YTD345.631-25.868-1,336%
P/E RatioN/AN/A-
Revenue00-
Total Cash103M3.13M3,296%
Total Debt8.29MN/A-
FUNDAMENTALS RATINGS
DBVT: Fundamental Ratings
DBVT
OUTLOOK RATING
1..100
65
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DBVTGLSI
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
75%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 18 days ago
81%
Bullish Trend 21 days ago
78%
Declines
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 2 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
Aroon
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
DBVT
Daily Signal:
Gain/Loss:
GLSI
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CMALX26.82N/A
N/A
Crawford Multi-Asset Income
TRGZX44.24-0.03
-0.07%
T. Rowe Price Emerging Markets Stock Z
HISCX24.51-0.06
-0.24%
Hartford Small Cap Growth HLS IA
GLPSX37.85-0.15
-0.39%
Goldman Sachs MLP Energy Infras R6
RYMKX62.61-0.28
-0.45%
Rydex Russell 2000 1.5x Strategy H

DBVT and

Correlation & Price change

A.I.dvisor tells us that DBVT and CRDF have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DBVT and CRDF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DBVT
1D Price
Change %
DBVT100%
+3.22%
CRDF - DBVT
32%
Poorly correlated
-2.18%
TAOX - DBVT
29%
Poorly correlated
-1.75%
GLSI - DBVT
29%
Poorly correlated
-1.71%
PASG - DBVT
26%
Poorly correlated
+21.82%
ALT - DBVT
26%
Poorly correlated
-1.17%
More

GLSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLSI has been loosely correlated with ABOS. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if GLSI jumps, then ABOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLSI
1D Price
Change %
GLSI100%
-1.71%
ABOS - GLSI
39%
Loosely correlated
-1.02%
CRSP - GLSI
39%
Loosely correlated
-5.47%
MNMD - GLSI
38%
Loosely correlated
-2.72%
EYPT - GLSI
37%
Loosely correlated
+2.96%
SRRK - GLSI
37%
Loosely correlated
+0.10%
More